The molecule, called CXCL5, is part of a family of proteins named chemokines that recruit inflammatory immune cells to injured tissue, triggering pain and tenderness.
Research carried out on rats showed a neutralizing antibody targeting CXCL5 significantly reduced sensitivity to sunburn pain, according to the study, to be published in Science Translational Medicine.
Read the Science Daily report on sunburn pain treatment.
Related Articles on Pain Management:
Psychiatrist Tackles Problem of Defining Pain Using Greek Philosophy
Stanford Hospital & Clinics to Open Headache Clinic
FDA Approves Lazanda Nasal Spray for Cancer Pain
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
